It Takes All of Us ” Casino Royale - Kidney Cancer Awareness Gala
The Dennis C. Baylor“BIG LUV” Kidney Cancer Foundation is proud to Announce that we will be hosting an elegant Evening with a purpose.Theme:“It Takes All of Us” Casino Royale - Kidney Cancer Awareness Gala to beheld:Friday November 24, 2017 at The Venue located at 10 Tallmadge Circle,Tallmadge OH 44278 - 8:00pm-1:00am This“Orange is The New Black” Semi-Formal event will feature Open Bar,Silent and Live auctions, Chef/Staff and entertainment. Guests will see a video tribute in memory of Dennis Baylor as well as hear inspirational storiesfrom kidney patients, caregivers, kidney d...
Source: Kidney Cancer Association - October 31, 2017 Category: Urology & Nephrology Source Type: news

Request for Proposals (RFP): Kidney Cancer Young Investigator Award (YIA)
The Kidney Cancer Association (KCA) invites proposals from young investigators for the 2018-2019 grant cycle. Young Investigator Award (YIA) abstracts are being accepted beginning October 30, 2017. The YIA is a one-year research grant totaling $50,000, which is paid in two equal installments to the awardee’s institution. Its aim is to provide funding to promising investigators to encourage and promote quality research in urology and clinical oncology. The awards given are based on individual merit and availability of funds. An applicant must have attained a postgraduate degree or a doctoral degree...
Source: Kidney Cancer Association - October 30, 2017 Category: Urology & Nephrology Source Type: news

CDMRP:Transforming Healthcare through Innovative and Impactful Research
Kidney Cancer Research (KCRP) has been funded by the CDMRP for many years under various programs including the Peer Reviewed Medical Research Program, Tuberous Sclerosis Complex Research Program, and, most recently, by the Peer Reviewed Cancer Research Program (PRCRP). From FY10 through FY16, the PRCRP invested over $9.8M in kidney cancer research. In FY17 the US Congress directed $10M to kidney cancer research in the DoD appropriation, thus establishing the Kidney Cancer Research Program.10/28/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - October 28, 2017 Category: Urology & Nephrology Source Type: news

Request for Proposals (RFP): Kidney Cancer Young Investigator Award (YIA)
The Kidney Cancer Association (KCA) invites proposals from young investigators for the 2018-2019 grant cycle. Young Investigator Award (YIA) abstracts are being accepted beginning October 30, 2017. The YIA is a one-year research grant totaling $50,000, which is paid in two equal installments to the awardee’s institution. Its aim is to provide funding to promising investigators to encourage and promote quality research in urology and clinical oncology. The awards given are based on individual merit and availability of funds. An applicant must have attained a postgraduate degree or a doctoral degree...
Source: Kidney Cancer Association - October 28, 2017 Category: Urology & Nephrology Source Type: news

Important support services at the fingertips of cancer patients
“Today, more than 15 million people in the United States are living with cancer and that number is expected to grow as emerging science and better therapies are likely to increase the number of patients living with cancer as we strive for a cure..."10/07/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - October 10, 2017 Category: Urology & Nephrology Source Type: news

Novel programs to put important support services at the fingertips of cancer patients
“Today, more than 15 million people in the United States are living with cancer and that number is expected to grow as emerging science and better therapies are likely to increase the number of patients living with cancer as we strive for a cure..."10/07/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - October 7, 2017 Category: Urology & Nephrology Source Type: news

Wanted: 1 million people to study genes, habits and health
In a quest to end cookie-cutter health care, U.S. researchers are getting ready to recruit more than 1 million people for an unprecedented study to learn how our genes, environments and lifestyles interact...10/05/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - October 5, 2017 Category: Urology & Nephrology Source Type: news

Dana Farber/Harvard Kidney Cancer Symposium
10th Annual Dana Farber/Harvard Cancer Center Kidney Cancer Symposium 09/28/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - September 28, 2017 Category: Urology & Nephrology Source Type: news

Will You Answer This Question? It Will Help To Determine The Future Of Patient Education
We're seeking your input on the planning of a large patient education meeting that would span two days and include presentations from leading experts from the major institutions...10/07/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - September 24, 2017 Category: Urology & Nephrology Source Type: news

FDA has approved biosimilar of Roche's Avastin
Amgen Inc. AMGN, -1.37% and Allergan AGN, -1.08% said Thursday that the Food and Drug Administration has approved their biosimilar version of Roche's Avastin for five types of cancer.09/15/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - September 15, 2017 Category: Urology & Nephrology Source Type: news

Department of Defense Kidney Cancer Research Program
The FY17 Defense Appropriations Act provides $10 million (M) to the Department of Defense Kidney Cancer Research Program (KCRP) to support United States Army Medical Research Acquisition Activity (USAMRAA). As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).09/30/201...
Source: Kidney Cancer Association - September 14, 2017 Category: Urology & Nephrology Source Type: news

Study Evaluating Opdivo in Combination with Yervoy Stopped Early for Demonstrating Overall Survival Benefit
The median PFS for the combination group was 11.6 months (95% CI: 8.71 to 15.51) versus 8.4 months (95% CI: 7.0 to 10.8) for the sunitinib group.09/17/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - September 11, 2017 Category: Urology & Nephrology Source Type: news

Kidney Cancer Guidelines
NCCN's Caitlyn Donnelly (left), Katy Winckworth-Prejsnar (center), and KCA's Paula Bowen (right) display Kidney Cancer Patient Guidelines® in French and German at the 2017 ESMO meeting in Madrid. Chinese and English translations are also available both online and in hardcopy from NCCN and KCA.09/12/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - September 11, 2017 Category: Urology & Nephrology Source Type: news